InsidersTradesSigma
Track the LeonaBio, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). The latest transaction was reported on 5 March 2026 (Levée d'options). Among the most active insiders: Renninger Robert. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
LeonaBio, Inc. is a company focused on developing innovative biopharmaceutical solutions. It specializes in the research and commercialization of treatments for serious diseases.